Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease

Pigment Cell Melanoma Res. 2009 Dec;22(6):851-3. doi: 10.1111/j.1755-148X.2009.00624.x. Epub 2009 Aug 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • DNA Mutational Analysis
  • Genetic Predisposition to Disease*
  • Humans
  • Levodopa / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Ultraviolet Rays / adverse effects

Substances

  • Levodopa